Top image

EDS: Primary Liver Cancer - Hepatology Meets Oncology

Education Dinner Series
November 2017
Sydney Catalyst

Education Dinner Series Event Report

Sydney Catalyst hosted an Education Dinner Series (EDS) event entitled Primary Liver Cancer - Hepatology meets Oncology on Wednesday 8th November 2018 to provide an introduction to and overview of some of the current issues and research in this disease.

Led by Professor Geoff McCaughan and with input from Associate Professor Philip Beale, a selection of speakers from across the translational research spectrum T1-T3 discussed why and how primary liver cancer is difficult but important. 

As for all of our EDS events, the evening provided a chance for members to meet and connect with a wide range of other Sydney Catalyst members in a relaxed environment.  

This event attaracted over 60 members and there was a robust Question and Answer session between the speakers and the audience.


  • Prof Geoff McCaughan: AW Morrow GE Liver Center, ANLTU, Centenary Research Institute RPAH, USyd
  • Dr Ken Liu: Centenary Research Institute
  • Dr Avik Majumdar: AW Morrow GE Liver Center, ANLTU, RPAH, USyd
  • Associate Professor Simone Strasser: AW Morrow GE Liver Centre, ANLTU, RPAH, USyd


 Associate Professor Philip Beale: Director, Cancer Services SLHD 


Primary liver cancer has become one of the top ten causes of cancer death in Australia and it is increasing, with almost 1,400 new diagnoses each year in Australia.

The most common cause of primary liver cancer is chronic viral hepatitis, and so many patients are already under the care of a gastroenterologist and/or heptologist at the time of diagnosis. As such, the treatment of primary liver cancer is often managed by these specialties (and others) outside of but in close collaboration with traditional cancer specialties. Tumour ablation, chemotherapy (often delivered directly into the tumour), and surgery are the most common treatment modalities. 

The unique aspects of the aetiology and treatment of primary liver cancer make it an important example of multi-disciplinary requiring close collaboration between many different types of researchers and clinicians. The increasing incidence makes it a priority.